CFX opus 96 real-time PCR instrument for quantitative real-time PCR.
Ended Awarded
- Contract number
- 75N91022F00002
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,999
Award facts
- Contract value 100% obligated
- $24,999.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rodeo, CA 94547, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract 75N91022F00002?
75N91022F00002 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on August 12, 2022.
How much is contract 75N91022F00002 worth?
The government has obligated $24,999 on 75N91022F00002.
Is contract 75N91022F00002 an order under another contract?
Yes. 75N91022F00002 is a BPA call under HHSN263201500172B, a blanket purchase agreement.
Was contract 75N91022F00002 competed?
The extent of competition for 75N91022F00002 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award